Healthcare-associated pneumonia: Meeting the yeti

European Respiratory Journal

Volumn 38, Issue 4, 2011, Pages 755-757

  Ewig, S ^a   Torres, A ^b  

^a Augusta Kranken Anstalt   (Germany)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; OXACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DISEASE TRANSMISSION; EDITORIAL; FUNCTIONAL STATUS; HEALTHCARE ASSOCIATED PNEUMONIA; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTIOUS PNEUMONIA; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; MULTIDRUG RESISTANCE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL;

COMMUNICABLE DISEASES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; HUMANS; PNEUMONIA, BACTERIAL;

EID: 80053531746     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00070011     Document Type: Editorial

References (26)

1. American Thoracic Society. Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
2. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results froma large US database of culture-positive pneumonia. Chest 2005; 128: 3854-3862. (Pubitemid 43062645)
3. Micek ST, Kollef KE, Reichley RM, et al. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51: 3568-3573. (Pubitemid 47519345)
4. Shindo Y, Sato S, Maruyama E, et al. Health-care-associated pneumonia among hospitalised patients in a Japanese community hospital. Chest 2009; 135: 633-640.
5. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest 2010; 137: 1283-1288.
6. Seki M, Hashiguchi K, Tanaka A, et al. Characteristics and disease severity of healthcare-associated pneumonia among patients in a hospital in Kitakyushu, Japan. J Infect Chemother 2011; 17: 363-369.
7. Park HK, Song JU, Um SW, et al. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir Med 2010; 104: 1729-1735.
8. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Health careassociated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167: 1393-1399. (Pubitemid 47052438)
9. Venditti M, Falcone M, Corrao S, et al. Outcomes of patients hospitalised with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009; 150: 19-26.
10. Garcia-Vidal C, Viasus D, RosetA, et al. Lowincidence ofmultidrugresistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 2011; [Epub ahead of print DOI: 10.1111/j.1469-0691.2011.03484.x].
11. Ewig S, Welte T, Chastre J, et al. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010; 10: 279-287.
12. Ewig S, Birkner N, Strauss R, et al. New perspectives on community-acquired pneumonia in 388406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009; 64: 1062-1069.
13. Rello J, Luján M, Gallego M, et al. Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest 2010; 137: 1138-1144.
14. Lambert ML, Suetens C, Savey A, et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011; 11: 30-38.
15. Shorr AF, Zilberberg MD, Micek ST, et al. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 2008; 168: 2205-2210.
16. Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 2011; 38: 878-887.
17. El Solh AA, Akinnusi ME, Alfarah Z, et al. Effect of antibiotic guidelines on outcomes of hospitalised patients with nursing home-acquired pneumonia. J Am Geriatr Soc 2009; 57: 1030-1035.
18. Labelle AJ, Arnold H, Reichley RM, et al. A comparison of culturepositive and culture-negative health-care-associated pneumonia. Chest 2010; 137: 1130-1137.
19. Kett DH, Cano E, Quartin AA, et al. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011; 11: 181-189.
20. Ewig S. Nosocomial pneumonia: de-escalation is what matters. Lancet Infect Dis 2011; 11: 155-157.
21. Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 2002; 162: 1849-1858.
22. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001; 18: 362-368. (Pubitemid 32776414)
23. Polverino E, Dambrava P, Cillóniz C, et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 2010; 65: 354-359.
24. El-Solh AA, Aquilina AT, Dhillon RS, et al. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am J Respir Crit Care Med 2002; 166: 1038-1043. (Pubitemid 35178700)
25. Zilberberg MD, Shorr AF. Healthcare-associated pneumonia: the state of evidence to date. Curr Opin Pulm Med 2011; 17: 142-147.
26. Seymann GB, Di Francesco L, Sharpe B, et al. The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumonia. Clin Infect Dis 2009; 49: 1868-1874.